Compare · BUD vs SRXH
BUD vs SRXH
Side-by-side comparison of Anheuser-Busch Inbev SA Sponsored ADR (Belgium) (BUD) and SRX Health Solutions Inc. (SRXH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BUD and SRXH operate in Beverages (Production/Distribution) (Consumer Staples), so they compete in similar markets.
- BUD is the larger of the two at $155.31B, about 4257.5x SRXH ($36.5M).
- SRXH has been more active in the news (6 items in the past 4 weeks vs 4 for BUD).
- BUD has more recent analyst coverage (25 ratings vs 0 for SRXH).
- Company
- Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
- SRX Health Solutions Inc.
- Price
- -
- -
- Market cap
- $155.31B
- $36.5M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Beverages (Production/Distribution)
- Beverages (Production/Distribution)
- Exchange
- NYSE
- AMEX
- IPO
- 2021
- News (4w)
- 4
- 6
- Recent ratings
- 25
- 0
Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
Anheuser-Busch InBev SA/NV engages in the production, distribution, and sale of beer, alcoholic beverages, and soft drinks worldwide. It offers a portfolio of approximately 500 beer brands, which primarily include Budweiser, Corona, and Stella Artois; Beck's, Hoegaarden, Leffe, and Michelob Ultra; and Aguila, Antarctica, Bud Light, Brahma, Cass, Castle, Castle Lite, Cristal, Harbin, Jupiler, Modelo Especial, Quilmes, Victoria, Sedrin, and Skol brands. The company was founded in 1366 and is headquartered in Leuven, Belgium. Anheuser-Busch InBev SA/NV is a subsidiary of AB InBev NV/SA.
Latest BUD
- Anheuser-Busch Invests $13 Million in Baldwinsville, NY Brewery, Expands Local Manufacturing Skills Training
- Tunnel to Towers Foundation & Anheuser-Busch Expand Longstanding Partnership in Honor of the 25th Anniversary of 9/11
- NYSE Content Update: Expedition Therapeutics Secures $115 Million Series B
- ‘Cheers to Beer’ Celebrates the Drink at the Heart of Life’s Meaningful Moments
- SEC Form 6-K filed by Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
- SEC Form 6-K filed by Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
- AB InBev Reports Second Quarter 2026 Results
- Anheuser-Busch InBev downgraded by Barclays
- New Oxford Economics Study Shows the Social and Economic Impact of Bars
- SEC Form 11-K filed by Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
Latest SRXH
- SRX Health Solutions Inc. filed SEC Form 8-K: Results of Operations and Financial Condition
- SEC Form 10-Q filed by SRX Health Solutions Inc.
- SRX Global Inc. Announces Fiscal Third Quarter 2026 Financial Results
- SRX Global to Host Fiscal Third Quarter 2026 Conference Call on August 13 at 4:30 p.m. ET
- SRX Global Acquires Stake in Vistagen Therapeutics (NASDAQ: VTGN)
- SRX Global Portfolio Company Smartkem, Inc. (NASDAQ: SMTK) Announces Merger
- SRX Global Acquires Shares in Jersey Mike’s $1 Billion Initial Public Offering
- Amendment: SRX Health Solutions Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities
- SRX Health Solutions Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities
- SRX Health Solutions Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits